NASDAQ:BNBX Applied Dna Sciences (BNBX) Stock Price, News & Analysis $0.15 0.00 (0.00%) As of 03:53 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsSEC FilingsTrendsBuy This Stock About Applied Dna Sciences Stock (NASDAQ:BNBX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Applied Dna Sciences alerts:Sign Up Key Stats Today's Range$0.14▼$0.1850-Day Range$0.08▼$0.5452-Week Range$0.07▼$7.15Volume125,480 shsAverage Volume489,772 shsMarket Capitalization$1.08 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains. Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers. The company supports those markers with laboratory services—using PCR and sequencing techniques—to analyze samples, produce digital chain-of-custody reports and provide verification for customers. Its business model includes product sales, licensing and contract testing or integration work tailored to customer requirements. Applied DNA’s solutions are used by organizations that need robust provenance and anti-counterfeiting measures, including manufacturers, distributors and entities in regulated industries. The company provides services to customers in the United States and internationally, seeking to address global supply-chain vulnerabilities by combining intellectual property, laboratory capability and field-deployable tagging technologies. Applied DNA Sciences is publicly traded on the NASDAQ.AI Generated. May Contain Errors. Read More Applied Dna Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks4th Percentile Overall ScoreBNBX MarketRank™: Applied Dna Sciences scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.5 / 5Analyst RatingSell Consensus RatingApplied Dna Sciences has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageApplied Dna Sciences has received no research coverage in the past 90 days.Read more about Applied Dna Sciences' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Applied Dna Sciences is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Applied Dna Sciences is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioApplied Dna Sciences has a P/B Ratio of 0.10. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.57% of the float of Applied Dna Sciences has been sold short.Short Interest Ratio / Days to CoverApplied Dna Sciences has a short interest ratio ("days to cover") of 0.64, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Applied Dna Sciences has recently increased by 213.01%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldApplied Dna Sciences does not currently pay a dividend.Dividend GrowthApplied Dna Sciences does not have a long track record of dividend growth. News and Social MediaN/ANews SentimentN/A Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Applied Dna Sciences insiders have not sold or bought any company stock.Percentage Held by Insiders6.14% of the stock of Applied Dna Sciences is held by insiders.Percentage Held by Institutions22.22% of the stock of Applied Dna Sciences is held by institutions.Read more about Applied Dna Sciences' insider trading history. Receive BNBX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Applied Dna Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BNBX Stock News HeadlinesBNB Plus Corp. (BNBX) Announces Nasdaq Delisting Determination and Transition to OTCQB Market; Company to Seek Review by Nasdaq Listing and Hearing Review CouncilJuly 13, 2026 | businesswire.comBNB Plus Corp. Announces Review of Strategic Alternatives to Maximize Shareholder ValueApril 20, 2026 | businesswire.comSee More Headlines BNBX Stock Analysis - Frequently Asked Questions How have BNBX shares performed this year? Applied Dna Sciences' stock was trading at $1.51 on January 27, 2026. Since then, BNBX stock has decreased by 90.1% and is now trading at $0.15. How were Applied Dna Sciences' earnings last quarter? Applied Dna Sciences Inc (NASDAQ:BNBX) released its quarterly earnings data on Friday, May, 15th. The company reported ($0.68) earnings per share for the quarter. The business earned $1.02 million during the quarter. Applied Dna Sciences had a negative net margin of 1,647.25% and a negative trailing twelve-month return on equity of 349.95%. How do I buy shares of Applied Dna Sciences? Shares of BNBX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/15/2026Today8/12/2026Fiscal Year End9/30/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (7m+) 1-Year History Aug 25 Nov 25 Feb 26 May 26 Aug 26 BNBX's financial health is in the Yellow zone, according to TradeSmith. BNBX has been in this zone for over 7 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:BNBX CIK744452 Webadnas.com Phone(631) 240-8800Fax631-240-8900Employees70Year FoundedN/AProfitability EPS (Trailing Twelve Months)($36.76) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$15.16 million Net Margins-1,647.25% Pretax Margin-1,671.00% Return on Equity-349.95% Return on Assets-283.96% Debt Debt-to-Equity RatioN/A Current Ratio1.82 Quick Ratio1.74 Sales & Book Value Annual Sales$2.09 million Price / Sales0.52 Cash FlowN/A Price / Cash FlowN/A Book Value$1.50 per share Price / Book0.10Miscellaneous Outstanding Shares7,197,000Free Float6,755,000Market Cap$1.08 million OptionableN/A Beta0.60 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:BNBX) was last updated on 8/12/2026 by MarketBeat.com Staff. From Our PartnersIran War: What Happened at 1:11 P.M. Outside D.C.?A source with ties to Saudi Arabia, the UAE, and the U.S. State Department revealed details of a potential 7 t...Banyan Hill Publishing | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | Sponsored$8B is moving in... are you?Venture capital investment in US crypto companies hit $7.9 billion last year, up 44 percent from the year befo...Awesomely | SponsoredNvidia's CEO says this small device is critical for AI growthA tiny glass device smaller than a fingertip could redefine AI hardware. Nvidia CEO Jensen Huang calls it esse...Brownstone Research | SponsoredThe government values gold at $42. It's really $4,800.The U.S. Treasury still values its gold reserves at 42.22 dollars an ounce, a price set in 1973. Gold trades n...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Dna Sciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied Dna Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.